Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Asparaginase Stories

2014-01-06 16:27:51

DUBLIN, Jan. 6, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 32(nd) Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Bruce C. Cozadd, chairman and chief executive officer, will provide an overview of the company and provide a business and financial update at the conference on Monday, January 13, 2014 at 10:00 a.m. PST / 6:00 p.m. GMT. A live audio webcast of the...

2013-11-20 16:26:50

DUBLIN, Nov. 20, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its participation at the 25th Annual Piper Jaffray Healthcare Conference in New York, NY. Bruce C. Cozadd, chairman and chief executive officer, will provide a corporate overview on Tuesday, December 3, at 8:30 a.m. EST / 1:30 p.m. GMT. A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website...

2013-11-01 08:27:06

DUBLIN, Nov. 1, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 2013 Credit Suisse Healthcare Conference in Phoenix, AZ. Bruce C. Cozadd, chairman and chief executive officer, will provide an overview of the company at the conference on Tuesday, November 12, at 11:30 a.m. MST / 6:30 p.m. GMT. A live audio webcast of the presentation may be accessed from the Investors section of the...

2013-04-23 16:25:33

DUBLIN, April 23, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its first quarter 2013 financial results on Tuesday, May 7, 2013, after the close of the financial markets. The announcement will be followed by a conference call and live webcast at 4:30 p.m. EDT/9:30 p.m. IST. During the call, company management will provide a business and financial update and review its first quarter 2013 results. A live webcast of the presentation...

2013-02-11 16:27:43

DUBLIN, Feb. 11, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Tuesday, February 26, 2013 at 4:30 p.m. EST/9:30 p.m. GMT. During the call, company management will provide a business and financial update and review its 2012 fourth quarter and full year financial results. A live webcast of the presentation may be accessed from the Investors & Media section of the Jazz Pharmaceuticals website at...

2013-01-02 16:22:38

DUBLIN, Jan. 2, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will webcast its presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2013. The webcast is scheduled to begin at 10:00 a.m. PST (6:00 p.m. GMT). Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals, will present an overview of the company and provide a business and financial update. The webcast can be...

2012-12-03 16:24:17

DUBLIN, Dec. 3, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled and dosed in a clinical trial of Erwinaze(®) (asparaginase Erwinia chrysanthemi) administered intravenously (IV) as an alternative method of administration to treat patients with acute lymphoblastic leukemia (ALL) with hypersensitivity to E. coli-derived asparaginase therapy. "Intravenous administration of Erwinaze may provide meaningful benefit to...

2012-11-05 16:28:23

DUBLIN, Nov. 5, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today its support of The Partnership at Drugfree.org's recently launched national action campaign, The Medicine Abuse Project. The initiative is intended as a multi-year public awareness and education campaign designed to curb abuse of prescription medicine among teens. A new study conducted by The Partnership at Drugfree.org found that medicine abuse is a growing problem among teens in the U.S., with...

2012-10-15 15:23:45

DUBLIN, Oct. 15, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of the sale of its women's health business to Meda (an international specialty pharmaceutical company) for $95 million in cash. The products included in the sale are Elestrin(®) (estradiol gel), Gastrocrom(®) (cromolyn sodium, USP), Natelle(® )One (prenatal vitamin), AVC(TM) Cream (sulfanilamide), Gesticare(®) DHA (prenatal multi-vitamin) and Urelle(®) (urinary...

2012-09-06 14:22:32

DUBLIN, Sept. 6, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate at the 2012 Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 11, 2012 at 9:45 a.m. EST / 2:45 p.m. GMT. Kate Falberg, executive vice president and chief financial officer, will provide a business update during a question and answer session with an analyst. A live webcast of the presentation may be accessed from the Investors section of...